Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07594119 · ClinicalTrials.gov registry record · Phase 3
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
A Phase 3 study, sponsored by Rapport Therapeutics.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 312
- Enrollment target
NCT07594119: Recruiting Phase 3 study, sponsored by Rapport Therapeutics.
NCT07594119 is a Phase 3 study that is actively recruiting participants, run by Rapport Therapeutics. The registered enrollment target is 312 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (60% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07594119, a Phase 3 study, is actively recruiting participants, sponsored by Rapport Therapeutics.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 312 participants
- Enrollment target
Study Summary
This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.
Primary Outcome
Median percent change in seizure frequency and ≥ 50% seizure frequency reduction responder rates
Interventions
- OTHER Placebo
- DRUG RAP-219
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 312 participants |
| Start Date | 2026-06 |
| Est. Completion | 2029-09 |
| Phase | Phase 3 |
What NCT07594119 shows while recruiting
NCT07594119 is an interventional study that assigns participants to a tested intervention. The registered 312 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (60% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT07594119 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07594119 about?
NCT07594119 is a clinical study titled "Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures". This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.
What is the current status of trial NCT07594119?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 312 participants. The study started on 2026-06. Estimated completion is 2029-09.
What interventions are being tested in trial NCT07594119?
The interventions under investigation include: Placebo (OTHER), RAP-219 (DRUG).
Who is sponsoring clinical trial NCT07594119?
This trial is sponsored by Rapport Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07594119's enrollment target sits among peer trials
312 1102nd of 2000 higher than 895 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04984551 · 312 participants · Phase 2
Impact of Project ECHO on Improving the Quality of Palliative Care in Patients With Advanced Cancer and Their Caregivers in Underserved Areas of Kenya, Nigeria, Ghana, South Africa, India, and Ethiopia
- NCT04999904 · 312 participants · NA
A Proprioceptive Training Program Using an Uneven Terrain Treadmill for Patients With Ankle Instability
- NCT05220332 · 312 participants · NA
Church-based Intervention to Improve Blood Pressure in African Americans
- NCT05434234 · 312 participants · Phase 1
A Study of YL201 in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia